| Net Cash Provided by (Used in) Operating Activities |
-49.3K |
USD |
-1073% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
48.9K |
USD |
+1249% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
480M |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
124M |
shares |
+2.58% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-375 |
USD |
+34.9% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
689K |
USD |
+1.8% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
689K |
USD |
+1.8% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
20M |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |